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http://dx.doi.org/10.1016/j.jds.2012.1Abstract Background/purpose: Betel quid (BQ) chewing is a popular habit in South-Asian and
Southeast Asian countries, and Taiwan. BQ chewing can cause oral cancer and oral submucous
fibrosis, and increases the risk of cardiovascular diseases. However, how BQ chewing affects
endothelial cells and is involved in cardiovascular diseases and vascular changes is not fully un-
derstood. The effects of arecoline, a component of BQ, on the growth and migration of endo-
thelial cells (EAhy 926), and their adherence by U937 cells were investigated.
Materials and methods: EAhy926 endothelial cells were cultured and exposed to various con-
centrations of arecoline for 24 hours. Morphological changes were observed using phase-
contrast microscopy. Cytotoxic effects were analyzed using a 3-(4,5-dimethyl-thiazol-2-yl)-
2,5-diphenyl-tetrazolium bromide assay. A wound closure assay was used to evaluate the
cellular migration of EAhy926 cells. The attachment of 20,70-bis-(2-carboxyethyl)-5-(6)-carbox-
yfluorescein-labeled U937 cells to EAhy926 endothelial cells that were pretreated with various
concentrations of arecoline was further studied.
Results: The addition of arecoline at concentrations >0.4 mM significantly decreased cellular
viability. EAhy endothelial cells showed marked morphological changes, and cellular migrationof Dentistry, National Taiwan University Hospital, 1 Chang-Te Street, Taipei 100, Taiwan.
(J.-H. Jeng).
as first authors.
iation for Dental Sciences of the Republic of China. Published by Elsevier Taiwan LLC. All rights reserved.
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Arecoline affects endothelial cell migration and adhesion 259decreased after 24 hours and 48 hours of exposure to arecoline. The number of U937 cells
attached to EAhy 926 cells increased when endothelial cells were pretreated by arecoline.
Conclusion: Arecoline impaired vascular endothelial cells by inhibiting their growth and migra-
tion and their adhesion to U937 mononuclear cells. These results reveal that arecoline may
contribute to the pathogenesis of oral submucous fibrosis and cardiovascular diseases by
affecting endothelial cell function in BQ chewers.
Copyright ª 2013, Association for Dental Sciences of the Republic of China. Published by
Elsevier Taiwan LLC. All rights reserved.Introduction
Betel quid (BQ) chewing is a popular oral habit in India, Sri
Lanka, Southeast Asian countries, and Taiwan.1e3 The
prevalence rate of the BQ chewing habit in Taiwan is esti-
mated to be about 10%; i.e. 2.0e2.8 million people have
experience of this habit.4 BQ is usually comprised of an
areca nut (AN, Areca catechu), slaked lime (calcium hy-
droxide) inside the betel leaf (Piper betle leaf), and
catechu, with or without tobacco.5 BQ chewing has become
the fourth most common oral habit in the world.3 In 2003,
the International Agency for Research on Cancer announced
that BQ and AN were confirmed to be carcinogens.6 This is
because the BQ chewing habit shows an intimate relation-
ship with the occurrence of oral cancer, oral leukoplakia,
and oral submucous fibrosis (OSF).2,3,7,8
BQ chewing increases the risk of cardiac arrhythmias,
sinus tachycardia,9 and cardiac dysrhythmias.10 BQ chewing
was shown to cause myocardial infarction, and arecoline is
considered to be a possible contributing factor to coronary
artery spasms due to its parasympathomimetic effects on
the vascular endothelium.11 The concentration of arecoline
in the ripe AN extract was 9.1 mg/g and up to about
140 mg/L in the saliva during BQ chewing.12 Arecoline, as a
major component of ANs, is a cholinergic alkaloid with the
ability to stimulate the central nervous system.13 Interest-
ingly, while the vascular density increased in the early
stage of OSF, the number of blood vessels obviously
decreased in the middle and advanced stages of OSF.14
Accordingly, the distribution of vascular endothelial cells
in the juxtaepithelial region of OSF tissues decreased as
observed histologically.15
The recruitment, migration, and adhesion of monocytes
to endothelial cells are early steps in many inflammatory
disorders including atherosclerosis.16 The adhesion of
monocytes to the vascular endothelium and their subse-
quent migration into the vessel wall are early events in this
disease process. In this study, we used EAhy 926 endothelial
(EAHY) cells,17 derived from the fusion of human umbilical
vein endothelial cells with a lung adenocarcinoma hybrid
cell line. EAHY cells express the characteristics of human
vascular endothelial cells.18
We recently demonstrated that arecoline inhibited the
proliferation of EAHY cells. Long-term exposure to areco-
line may potentially damage the vascular endothelium.
These results may lead to vascular changes and cytotoxic
effects and potentially contribute to BQ chewing-related
cardiovascular diseases (CVDs).19 However, the precise
factors and reasons responsible for the vascular changes in
OSF and the increased risk of CVD mortality with the BQchewing habit are still not fully clear. In this study, we
propose that arecoline may contribute to CVDs and oral
mucosal alterations by causing endothelial cell damage and
dysfunction. We therefore evaluated the effects of areco-
line in inhibiting the growth and migration of human
endothelial cells and their attachment to U937 mono-
nuclear cells.
Materials and methods
Chemicals
Arecoline hydrobromide, 3-(4,5-dimethyl-thiazol-2-yl)-
2,5-diphenyl-tetrazolium bromide (MTT), and dimethyl
sulfoxide (DMSO) were purchased from Sigma (St. Louis,
MO, USA). Dulbecco’s modified Eagle’s medium (DMEM),
fetal bovine serum (FBS) penicillin/streptomycin, trypsin/
EDTA, phosphate-buffered saline (PBS), glutamine, trypan
blue, and RPMI 1640 culture medium were obtained
from Gibco (Life Technologies, Grand Island, NY, USA).
Molecular Probes (Eugene, OR, USA) supplied 20,70-Bis-(2-
carboxyethyl)-5-(6)-carboxyfluorescein acetoxy methyl
ester (BCECF-AM).
Culture of EAHY and U937 cells
EAHY cells were derived from a human endothelial hybrid
cell line. They were kindly provided by Dr Cora-Jean
S. Edgell (University of North Carolina, Chapel Hill, NC,
USA)17 and cultured in DMEM containing 10% FBS and 5%
CO2 at 37
C. Human monocytic U937 cells were a kind gift
from Professor Shan-Ling Hung (Dental School, National
Yang Ming University, Taipei, Taiwan). They were main-
tained in RPMI 1640 medium containing 10% FBS and 5% CO2
at 37 C in an incubator. U937 cells were cultured in sus-
pension in plastic culture flasks. Cells were split with fresh
media 1: 5 every 3e4 days. The viability of U937 cells was
examined by a trypan blue dye exclusion method and
found to exceed 95%.
Effects of arecoline on the growth of EAHY cells
Viable cell numbers were measured by a modified MTT
assay.20 Briefly, EAHY cells were seeded at an initial density
of 5  105 cells/well in a 6-well plate for 24 hours. Cells
were then exposed to fresh medium containing various
concentrations of arecoline (0 mM, 0.1 mM, 0.2 mM,
0.4 mM, and 0.8 mM) for 1 day or 5 days. MTT (at a final
concentration of 0.5 g/L) was then added to the wells and
260 S.-K. Tseng et alcultured for a further 3 hours. The culture medium was
decanted. The insoluble formazan produced by viable cells
was dissolved in DMSO and read against a blank (DMSO) at
OD540 using a plate reader (Dynatech Microwell, Dynatech,
Alexandria, VA, USA) Results are expressed as MTT reduc-
tion (mean  standard error of mean as a percent of the
control).
Effects of arecoline on the migration of EAHY cells
EAHY cells were cultured on six-well plates at a concen-
tration of 5  105 cells/well and cultured for 48 hours.
The cell layer on the plates was scratched with a 100-mL
pipette tip. The wounded areas were marked at the start
time and photographed with a microscope (Olympus TH4-
100 and Olympus IX71; Olympus America Inc., Center
Valley, PA, USA). EAHY cells were then exposed to me-
dium with/without different concentrations of arecoline
(0 mM, 0.1 mM, 0.2 mM, and 0.4 mM) for 16 hours and 24
hours. Cells were photographed at the same sites for
comparison.
Effects of arecoline treatment of EAHY cells on the
adhesion to U937 cells
An adhesion study of U937 cells to endothelial cells was
performed using an established model.21 Briefly, U937 cells
were labeled with the membrane-permeable dye, BCECF-
AM (3mM), in RPMI-1640 for 30 minutes in a 37 C incu-
bator. Cells were then centrifuged and resuspended in
serum-free medium before use.Figure 1 (A) Morphology of untreated EAHY cells after 24 hours o
cuboid or spindle-shaped in appearance. (B) Morphology of EAHY ce
cells had become retracted and rounded after exposure to 0.4 mM a
of culture. (D) Morphology of EAHY cells after exposure to 0.2 mM
floating cells were noted (100, original magnification).Confluent EAHY cells grown in six-well tissue culture
plates were treated with various concentrations of areco-
line (0 mM, 0.01 mM, 0.05 mM, 0.1 mM, 0.2 mM, and
0.4 mM) for 24 hours. Control wells received only vehicle
and were used as the negative control. After arecoline
stimulation, EAHY cells were washed with PBS, and then
4  105 BCECF-labeled U937 cells/well were added and
allowed to attach at 37 C for 30 minutes. Thereafter, the
medium was decanted, and cells were washed with RPMI-
1640 medium. Unbound U937 cells were removed by
washing with serum-free medium, and attached U937 cells
(green fluorescence) were observed and photographed
under a fluorescent microscope (Olympus TH4-100 and
Olympus IX71; Olympus America).
For quantification of the fluorescence of attached
BCECF-labeled U937 cells, the emitted BCECF fluorescence
of cultured wells was measured with a Gemini XPS
Microplate Spectrofluorometer (Molecular Devices, North
America, Sunnyvale, CA, USA). The fluorescence of BCECF-
labeled U937 cells attached to untreated EAHY cells was
used as the control.Statistical analysis
At least three or more separate experiments were per-
formed for all tests. Results were analyzed by one-way
analysis of variance (ANOVA) and post hoc Tukey’s test
to check differences between groups. A P value of <0.05
was considered to indicate a statistically significant
difference.f culture. Cell growth had reached confluence. EAHY cells were
lls after exposure to 0.4 mM arecoline for 24 hours. Some EAHY
recoline for 24 hours. (C) Morphology of EAHY cells after 5 days
arecoline for 5 days. The cell density had decreased, and some
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Morphological changes to EAHY cells
Cultured EAHY endothelial cells were generally spindle or
cuboid in appearance. (Fig. 1A) Some of the EAHY cells
became retracted and lost the extended cellular processes.
Some cells were rounded and had even detached from the
culture plate after exposure to 0.4 mM arecoline for 24
hours (Fig. 1B). EAHY cells were confluent after 72 hours in
culture (Fig. 1C). After 72 hours in culture, even 0.2 mM
arecoline induced morphologic changes in EAHY cells with a
decrease in the cell density and some floating cells being
noted (Fig. 1D).
Cytotoxicity of arecoline to EAHY endothelial cells
Quantitatively, 24 hours of exposure to arecoline was
cytotoxic and decreased the number of viable EAHY cells
by 32% at a concentration of 0.8 mM as analyzed by
the MTT assay (Fig. 2A). After incubation for 5 days,Figure 2 Cytotoxicity of arecoline to EAHY endothelial cells
as estimated by an MTT assay. (A) Viable cell numbers (% of
control) after exposure of EAHY cells to arecoline for 24 hours
(nZ 5). (B) Viable cell numbers (% of control) after exposure of
EAHY cells to arecoline for 5 days (n Z 3). * Denotes a signif-
icant difference compared to the untreated group (P < 0.05).arecoline at concentrations of 0.2e0.8 mM caused a
further decline in viable cells to <20% of the control
(Fig. 2B).
Arecoline inhibits the migration of EAHY cells
A wound closure assay was used to evaluate EAHY cell
migration. The migration of EAHY cells toward the
wounded area was noted in the control culture after 16
hours. The wound had almost closed after 24 hours of
incubation (Fig. 3A). Similarly, EAHY cells migrated to the
wound area after exposure to 0.1 mM arecoline for 16
hours and 24 hours, but the extent of wound closure was
less than that of the control (Fig. 3B). At a concentration
of 0.2 mM, arecoline further attenuated the wound
closure activity by EAHY cells (Fig. 3C). Marked cytotox-
icity was noted when cells were exposed to 0.4 mM
arecoline (data not shown).Figure 3 Closure of a wound by EAHY cells photographed
initially (0 hours) and after 16 hours and 24 hours of incubation
with or without arecoline. (A) Control cells, (B) 0.1 mM arec-
oline. Compared to the control, fewer EAHY cells had migrated
into the wounded area after exposure to 0.1 mM arecoline for
16 hours and 24 hours. (C) Arecoline at 0.2 mM. The migration
of EAHY cells into the wounded area was markedly inhibited.
Dotted lines (- - -) indicate the original wounded area. (40,
original magnification).
Figure 5 The extent of U937 cell attachment to EAHY cells
was further evaluated with a fluorescent plate reader. Stimu-
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EAHY cells
Treatment of EAHY cells with arecoline enhanced their
attachment to BCECF-labeled U937 mononuclear cells. As
observed under fluorescence microscopy, BCECF-labeled
U937 cells showed green fluorescence. Some U937 cells may
have attached to untreated EAHY cells (Fig. 4A). Exposure
of EAHY cells to 0.1 mM and 0.4 mM arecoline provided a
cell layer for the attachment of U937 cells, as indicated by
an increase in the number of attached U937 cells (green
fluorescence) under fluorescence microscopy (Fig. 4B,C).
Quantitatively, exposure of EAHY cells to arecoline
promoted the adhesion of U937 mononuclear cells with a
maximal stimulation at a concentration of 0.1 mM
(P < 0.05). The fluorescence of culture wells increased
from 287 relative fluorescent units (in the control) to 477
relative fluorescent units (in the 0.1 mM arecoline-treated
EAHY cell group; Fig. 5). No further increase was notedFigure 4 Effect of arecoline treatment of EAHY cells on
adhesion to U937 mononuclear cells. (A) Control well.
Compared to the control well, an increase in the number of
attached U937 cells was found after exposure of EAHY cells to
0.1 mM (B) or 0.4 mM arecoline (C). BCECF-labeled U937
mononuclear cells are round cells with green fluorescence,
while EAHY cells showed the background color (100, original
magnification).
lation of U937 attachment to EAHY cells was noted, as shown
by the increase in BCECF fluorescence in the 0.1 mM arecoline-
treated group. Results are expressed as mean  standard error
of the mean relative fluorescent units (n Z 5). * Denotes a
statistically significant difference compared to control wells.when the concentrations of arecoline were elevated to
0.2 mM and 0.4 mM, possibly due to cytotoxicity.
Discussion
In the present study, we clearly demonstrated that areco-
line is cytotoxic to EAHY endothelial cells in a dose-
dependent manner. EAHY cells showed morphological
changes and detached from the culture dish after exposure
to 0.4e0.8 mM arecoline. Viabilities of EAHY cells were 88%
and 68% of the control, respectively. Arecoline inhibited
the migration of EAHY cells, but increased the adhesion of
U937 cells to EAHY cells. Effects of arecoline on the cyto-
toxicity, migration, and mononuclear cell adhesion to
endothelial cells may contribute to the pathogenesis of
periodontal disease, OSF, and BQ chewing-related CVDs via
toxicity to oral or systemic endothelial cells, leading to the
impairment of vascular function.19
Endothelial cells of blood vessels lie between smooth
muscle cells of blood vessels and blood flow. Endothelial
cells may release various inflammatory mediators such as
prostanoids to modulate tissue inflammation, fibrosis, and
cancer. Arecoline was shown to inhibit the growth,
attachment, spread, and collagen synthesis of human
gingival fibroblasts (GFs).22 Chang et al23 also demonstrated
that arecoline inhibited the proliferation and collagen
synthesis of human GFs. Arecoline significantly inhibited
human periodontal ligament fibroblast proliferation,
decreased protein synthesis, and significantly depleted
intracellular thiols.24 Moreover, arecoline induced cell
cycle deregulation and apoptosis in GFs.25 Arecoline also
inhibited p53, repressed DNA repair, and triggered a DNA
damage response in human epithelial cells.26 Arecoline may
suppress mitochondrial activation, deplete intracellular
thiols, and influence the cell function of GFs.27 Accordingly,
arecoline was cytotoxic to endothelial cells in this study.
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and increase vascular permeability that is crucial for tissue
inflammation. This result suggests that, during BQ chewing,
endothelial cell damage may be induced by BQ compo-
nents, leading to oral mucosal inflammatory responses,
and inflammation of the vasculature may increase in-
cidences of atherosclerosis, thrombosis, hypertension, and
other CVDs.28e31
Nair et al examined the salivary arecoline content and
found it to be 0e89.8 mg/L among BQ chewers, with an
average of 29.69 mg/L.12 AN components and arecoline may
stimulate glucagon and catecholamine secretions which
contribute to diabetes and CVDs.32 Arecoline directed
leukocyte migration and exhibited an inhibitory effect on
the functions of neutrophils at high concentrations.33
Endothelial migration is important for endothelial repair
after arterial injury,34 and this event is impaired during
aging and diseased conditions such as oxidative stress,
atherosclerosis, diabetes mellitus, prehypertension,
etc.35e37 In this study, we found that arecoline at
0.1e0.2 mM may have adversely affected endothelial
migration. This might partly explain why BQ chewing ele-
vates oxidative stress and increases the risk of atheroscle-
rosis, diabetes mellitus, hypertension, and heart disease in
epidemiological studies.38,39
Atherosclerosis is a chronic low-grade inflammatory
disorder.40 Activated endothelial cells secrete interleukin-
8, an inflammatory cytokine that can induce adhesion
molecules.41 The adhesion of monocytes to the vascular
endothelium and their subsequent migration into the vessel
wall may change the integrity and are pivotal early events
in tissue inflammation and CVDs.30 These infiltrating
inflammatory cells include monocytes, macrophages,
neutrophils, and lymphocytes.42 Inflammatory cells may
further generate various mediators and growth factors
involved in the pathogenesis of vascular diseases. Inter-
estingly, we found that arecoline treatment of endothelial
cells promotes their attachment to U937 mononuclear cells
as observed under fluorescence microscopy and quantifi-
cation of attached fluorescent-labeled U937 mononuclear
cells. Chang et al pointed out that abnormal growth of
fibroblasts and matrix deposition can be a mechanism of
OSF.43,44 Tissue sections of OSF exhibited a lot of inflam-
matory cell infiltration that may have a close relation to the
induction of abnormal inflammation by BQ ingredients.45
These results suggest that arecoline may be involved in
the disease processes of atherosclerosis and oral mucosal
diseases by inducing vascular changes and tissue
inflammation.
In conclusion, arecoline may inhibit the growth and
migration of human endothelial cells. Exposure to arecoline
potentially damages the vascular endothelium and induces
tissue inflammation via increasing the attachment to U937
monocytes. These effects of arecoline on endothelial cells
may be associated with BQ chewing-related CVDs, OSF, and
periodontal diseases.Conflicts of interest
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